drugset / Trial / NCT01382888

Efficacy and Local Tolerability of Topically Applied Heparin on the Suitability of Newly Constructed Primary Arteriovenous Fistulas in Patients Planned for Haemodialysis

NCT01382888

Phase 2 Terminated 30 enrolled Cyathus Exquirere Pharmaforschungsgmbh
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The primary objective of this study is to evaluate the effect of topically applied heparin in comparison to placebo on suitability of newly constructed primary arteriovenous fistulas in patients planned for haemodialysis at 7th week (± 1 week) after first study drug administration.

Timeline

Start
2011-07
Primary completion
2014-04
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Heparin Other / unclassified 2400 unknown Topical

Indications

No indication recorded.